ARCHIVES

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

September 3, 1976

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974